Published in Neuroscience on January 01, 1989
Dichotomous dopaminergic control of striatal synaptic plasticity. Science (2008) 5.47
Dopamine signals for reward value and risk: basic and recent data. Behav Brain Funct (2010) 3.42
Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat Neurosci (2009) 3.38
Regional specificity in the real-time development of phasic dopamine transmission patterns during acquisition of a cue-cocaine association in rats. Eur J Neurosci (2009) 2.22
Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J Neurosci (2009) 2.16
Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology (2010) 2.14
Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J Neurosci (2008) 1.97
Dynamic changes in accumbens dopamine correlate with learning during intracranial self-stimulation. Proc Natl Acad Sci U S A (2008) 1.77
Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway. Brain Res Rev (2008) 1.75
Neurocomputational models of basal ganglia function in learning, memory and choice. Behav Brain Res (2008) 1.71
Differential innervation of direct- and indirect-pathway striatal projection neurons. Neuron (2013) 1.69
Dopamine release in the basal ganglia. Neuroscience (2011) 1.67
Oxytocin reverses amphetamine-induced deficits in social bonding: evidence for an interaction with nucleus accumbens dopamine. J Neurosci (2014) 1.51
Timing is not Everything: Neuromodulation Opens the STDP Gate. Front Synaptic Neurosci (2010) 1.50
Aversive stimuli drive drug seeking in a state of low dopamine tone. Biol Psychiatry (2014) 1.50
Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens. J Neurochem (2012) 1.37
Basolateral amygdala modulates terminal dopamine release in the nucleus accumbens and conditioned responding. Biol Psychiatry (2009) 1.36
Endocytosis promotes rapid dopaminergic signaling. Neuron (2011) 1.35
Schizophrenia in translation: the presence of absence: habenular regulation of dopamine neurons and the encoding of negative outcomes. Schizophr Bull (2006) 1.33
Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. J Neurosci (2013) 1.33
The dopaminergic basis of human behaviors: A review of molecular imaging studies. Neurosci Biobehav Rev (2009) 1.30
Nucleus accumbens dopamine mediates amphetamine-induced impairment of social bonding in a monogamous rodent species. Proc Natl Acad Sci U S A (2009) 1.29
Dopaminergic control of cognitive flexibility in humans and animals. Front Neurosci (2013) 1.28
Absence of NMDA receptors in dopamine neurons attenuates dopamine release but not conditioned approach during Pavlovian conditioning. Proc Natl Acad Sci U S A (2010) 1.26
Dopamine regulation of social choice in a monogamous rodent species. Front Behav Neurosci (2009) 1.25
Dopaminergic signaling in dendritic spines. Biochem Pharmacol (2008) 1.23
Dopamine receptors in a songbird brain. J Comp Neurol (2010) 1.20
Encoding of aversion by dopamine and the nucleus accumbens. Front Neurosci (2012) 1.13
Convergent evidence for abnormal striatal synaptic plasticity in dystonia. Neurobiol Dis (2009) 1.13
The time course of dopamine transmission in the ventral tegmental area. J Neurosci (2009) 1.10
Rapid, sensitive detection of neurotransmitters at microelectrodes modified with self-assembled SWCNT forests. Anal Chem (2012) 1.09
Carbon-fiber microelectrodes modified with 4-sulfobenzene have increased sensitivity and selectivity for catecholamines. Langmuir (2006) 1.09
Aversive behavior induced by optogenetic inactivation of ventral tegmental area dopamine neurons is mediated by dopamine D2 receptors in the nucleus accumbens. Proc Natl Acad Sci U S A (2014) 1.07
Rapid dopamine signaling differentially modulates distinct microcircuits within the nucleus accumbens during sucrose-directed behavior. J Neurosci (2011) 1.07
Balanced NMDA receptor activity in dopamine D1 receptor (D1R)- and D2R-expressing medium spiny neurons is required for amphetamine sensitization. Proc Natl Acad Sci U S A (2011) 1.06
The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors. Prog Neurobiol (2015) 1.06
Dopaminergic Control of the Exploration-Exploitation Trade-Off via the Basal Ganglia. Front Neurosci (2012) 1.04
Positive reinforcement mediated by midbrain dopamine neurons requires D1 and D2 receptor activation in the nucleus accumbens. PLoS One (2014) 1.04
Dissociable effects of dopamine on neuronal firing rate and synchrony in the dorsal striatum. Front Integr Neurosci (2009) 1.03
The contribution of NMDA receptor signaling in the corticobasal ganglia reward network to appetitive Pavlovian learning. J Neurosci (2011) 0.99
Pharmacologic neuroimaging of the ontogeny of dopamine receptor function. Dev Neurosci (2010) 0.98
Capturing dopaminergic modulation and bimodal membrane behaviour of striatal medium spiny neurons in accurate, reduced models. Front Comput Neurosci (2009) 0.96
Establishing causality for dopamine in neural function and behavior with optogenetics. Brain Res (2012) 0.96
Phasic dopamine release drives rapid activation of striatal D2-receptors. Neuron (2014) 0.95
Stimulus-response and response-outcome learning mechanisms in the striatum. Behav Brain Res (2008) 0.93
Functional significance of central D1 receptors in cognition: beyond working memory. J Cereb Blood Flow Metab (2012) 0.93
Electrophysiological evidence of mediolateral functional dichotomy in the rat nucleus accumbens during cocaine self-administration II: phasic firing patterns. Eur J Neurosci (2010) 0.93
Investigating striatal function through cell-type-specific manipulations. Neuroscience (2011) 0.92
Recent trends in carbon nanomaterial-based electrochemical sensors for biomolecules: A review. Anal Chim Acta (2015) 0.91
Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease. Front Syst Neurosci (2011) 0.91
Mesolimbic dopamine transients in motivated behaviors: focus on maternal behavior. Front Psychiatry (2011) 0.90
Dopaminergic and cholinergic learning mechanisms in nicotine addiction. Ann N Y Acad Sci (2015) 0.89
Amphetamine alters behavior and mesocorticolimbic dopamine receptor expression in the monogamous female prairie vole. Brain Res (2010) 0.89
The external globus pallidus: progress and perspectives. Eur J Neurosci (2016) 0.89
Sex differences in effects of dopamine D1 receptors on social withdrawal. Neuropharmacology (2013) 0.88
A behavioral genetics approach to understanding D1 receptor involvement in phasic dopamine signaling. Mol Cell Neurosci (2010) 0.88
Dopamine-mediated learning and switching in cortico-striatal circuit explain behavioral changes in reinforcement learning. Front Behav Neurosci (2011) 0.87
Toward sophisticated basal ganglia neuromodulation: Review on basal ganglia deep brain stimulation. Neurosci Biobehav Rev (2015) 0.85
Voluntary exercise improves performance of a discrimination task through effects on the striatal dopamine system. Learn Mem (2014) 0.82
A molecular dissociation between cued and contextual appetitive learning. Learn Mem (2010) 0.81
Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens. Br J Pharmacol (1995) 0.81
Mitochondrial abnormalities in the putamen in Parkinson's disease dyskinesia. Acta Neuropathol (2010) 0.81
Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation. J Neurochem (2013) 0.80
Amphetamine mechanisms and actions at the dopamine terminal revisited. J Neurosci (2013) 0.80
Differential relationships between D1 and D2 dopamine receptor expression in the medial preoptic nucleus and sexually-motivated song in male European starlings (Sturnus vulgaris). Neuroscience (2015) 0.80
Cannabinoid modulation of drug reward and the implications of marijuana legalization. Brain Res (2014) 0.80
Comodulation of dopamine and serotonin on prefrontal cortical rhythms: a theoretical study. Front Integr Neurosci (2013) 0.79
Application of cross-species PET imaging to assess neurotransmitter release in brain. Psychopharmacology (Berl) (2015) 0.79
A mutation in CLOCK leads to altered dopamine receptor function. J Neurochem (2012) 0.79
Striatal dopamine neurotransmission: regulation of release and uptake. Basal Ganglia (2016) 0.79
Learning Reward Uncertainty in the Basal Ganglia. PLoS Comput Biol (2016) 0.79
A comparison of the subsecond dynamics of neurotransmission of dopamine and serotonin. ACS Chem Neurosci (2013) 0.78
Further evaluation of the carbon11-labeled D(2/3) agonist PET radiotracer PHNO: reproducibility in tracer characteristics and characterization of extrastriatal binding. Synapse (2010) 0.78
Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease. J Huntingtons Dis (2012) 0.78
Dopamine and opioid systems interact within the nucleus accumbens to maintain monogamous pair bonds. Elife (2016) 0.78
Chronic cocaine disrupts mesocortical learning mechanisms. Brain Res (2015) 0.78
Safety out of control: dopamine and defence. Behav Brain Funct (2016) 0.77
Nucleus accumbens core neurons encode value-independent associations necessary for sensory preconditioning. Behav Neurosci (2014) 0.77
Adolescent brain maturation is necessary for adult-typical mesocorticolimbic responses to a rewarding social cue. Dev Neurobiol (2013) 0.77
Milnacipran enhances the control of impulsive action by activating D₁-like receptors in the infralimbic cortex. Psychopharmacology (Berl) (2012) 0.77
Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist. Mol Pharmacol (2016) 0.77
Divergent effect of the selective D3 receptor agonist pd-128,907 on locomotor activity in Roman high- and low-avoidance rats: relationship to NGFI-A gene expression in the Calleja islands. Psychopharmacology (Berl) (2007) 0.77
Specific contributions of N-methyl-D-aspartate receptors in the dorsal striatum to cognitive flexibility. Neuroscience (2014) 0.77
DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine. Psychopharmacology (Berl) (2014) 0.77
Activation of D2 dopamine receptor-expressing neurons in the nucleus accumbens increases motivation. Nat Commun (2016) 0.76
Computing reward-prediction error: an integrated account of cortical timing and basal-ganglia pathways for appetitive and aversive learning. Eur J Neurosci (2015) 0.76
Decoding the dopamine signal in macaque prefrontal cortex: a simulation study using the Cx3Dp simulator. PLoS One (2013) 0.76
Many Roads to Motor Deficits: Loss of Dopamine Signaling in Direct or Indirect Basal Ganglia Pathway Leads to Akinesia through Distinct Physiological Mechanisms. Front Neurosci (2010) 0.76
Dopamine Rebound-Excitation Theory: Putting Brakes on PTSD. Front Psychiatry (2016) 0.75
Food Restriction Induces Synaptic Incorporation of Calcium-Permeable AMPA Receptors in Nucleus Accumbens. Eur J Neurosci (2017) 0.75
Daily Exposure to Sucrose Impairs Subsequent Learning About Food Cues: A Role for Alterations in Ghrelin Signaling and Dopamine D2 Receptors. Neuropsychopharmacology (2015) 0.75
Prenatal exposure to methylphenidate affects the dopamine system and the reactivity to natural reward in adulthood in rats. Int J Neuropsychopharmacol (2014) 0.75
Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum. Psychopharmacology (Berl) (2008) 0.75
The functional anatomy of basal ganglia disorders. Trends Neurosci (1989) 12.28
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet (2000) 3.07
Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature (1999) 2.97
Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A (1988) 2.78
Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology (2000) 2.49
Homozygotes for Huntington's disease. Nature (1987) 2.40
Strychnine binding associated with glycine receptors of the central nervous system. Proc Natl Acad Sci U S A (1973) 2.37
Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proc Natl Acad Sci U S A (1974) 2.29
Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci U S A (1998) 2.14
Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. N Engl J Med (1973) 1.90
Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med (1990) 1.89
Studies of the antigenic relationships of the new human papovaviruses by electron microscopy agglutination. Infect Immun (1973) 1.84
Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol (1997) 1.82
Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol (1987) 1.78
Glutamic acid: selective depletion by viral induced granule cell loss in hamster cerebellum. Brain Res (1974) 1.77
Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord (1990) 1.76
Synaptic biochemistry of amino acids. Fed Proc (1973) 1.74
Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol (1994) 1.73
Huntington disease: no evidence for locus heterogeneity. Genomics (1989) 1.70
Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci (1994) 1.67
The functional anatomy of disorders of the basal ganglia. Trends Neurosci (1995) 1.62
Treatment for patients with cerebral metastases. Arch Neurol (1978) 1.60
Evaluation of traumatic atlantooccipital dislocations. AJNR Am J Neuroradiol (1987) 1.57
PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol (1986) 1.53
Initial therapy of patients with Wilson's disease with tetrathiomolybdate. Arch Neurol (1991) 1.53
Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites. J Pharmacol Exp Ther (1985) 1.44
Papovavirus of JC type in progressive multifocal leukoencephalopathy. Rapid identification and subsequent isolation. Arch Neurol (1973) 1.43
Interaction of benzodiazepines with central nervous glycine receptors: possible mechanism of action. Proc Natl Acad Sci U S A (1974) 1.41
Huntington's disease in Venezuela: neurologic features and functional decline. Neurology (1986) 1.39
NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J Neurosci (1995) 1.37
At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan. Am J Med Genet (1987) 1.34
Virions from progressive multifocal leukoencephalopathy: rapid serological identification by electron microscopy. Science (1972) 1.33
Distribution and kinetics of GABAB binding sites in rat central nervous system: a quantitative autoradiographic study. Neuroscience (1990) 1.32
Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann Neurol (1992) 1.31
Primary culture of capillary endothelium from rat brain. In Vitro (1981) 1.30
Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann Neurol (1990) 1.29
Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. J Chem Neuroanat (2004) 1.27
Neuronal and oligodendroglial infection by the WW strain of Theiler's virus. Lab Invest (1979) 1.25
Excitatory amino acids and Alzheimer's disease. Neurobiol Aging (1989) 1.24
Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann Neurol (2000) 1.23
NMDA receptor losses in putamen from patients with Huntington's disease. Science (1988) 1.21
Hypoxanthine-guanine phosphoribosyltransferase deficiency. The molecular basis of the clinical syndromes. N Engl J Med (1983) 1.21
Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. Brain Res Mol Brain Res (1996) 1.21
Expression of normal and mutant huntingtin in the developing brain. J Neurosci (1996) 1.21
Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm (Vienna) (2005) 1.20
Speculations on the functional anatomy of basal ganglia disorders. Annu Rev Neurosci (1983) 1.18
Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics (2001) 1.18
Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease. Philos Trans R Soc Lond B Biol Sci (1999) 1.18
Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann Neurol (1998) 1.16
Quantitative autoradiographic distribution of L-[3H]glutamate-binding sites in rat central nervous system. J Neurosci (1984) 1.15
Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia. J Comp Neurol (1999) 1.14
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J Neurosci (1998) 1.14
Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus. Brain Res Mol Brain Res (1997) 1.14
Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain. Ann Neurol (1999) 1.12
Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons. J Comp Neurol (1995) 1.12
Striatal inhomogeneities and basal ganglia function. Mov Disord (1986) 1.11
Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapy. Ann Neurol (1977) 1.10
Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease. Arch Neurol (1995) 1.09
Wilson disease of the brain: MR imaging. Radiology (1985) 1.09
Imaging of a glioma using peripheral benzodiazepine receptor ligands. Proc Natl Acad Sci U S A (1987) 1.09
Brain mechanisms associated with therapeutic actions of benzodiazepines: focus on neurotransmitters. Am J Psychiatry (1977) 1.08
The glycine synaptic receptor: evidence that strychnine binding is associated with the ionic conductance mechanism. Proc Natl Acad Sci U S A (1974) 1.06
Toe fusion using Kirschner wire. A study of the postoperative infection rate and related problems. J R Coll Surg Edinb (1987) 1.06
Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex. J Comp Neurol (1998) 1.05
Career change: in quest of a controllable lifestyle. J Surg Res (1989) 1.04
Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function. Ann Neurol (1988) 1.04
Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. Brain Res Mol Brain Res (1999) 1.04
Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J Neurochem (1985) 1.04